OmniAb Investor Conference Presentation Deck

OmniAb, Inc. Summary ● ● ● Demand for antibody-based approaches drives the industry's need for cutting-edge discovery technologies We maintain a highly scalable business where investments in and extensions of our differentiated technology are informed by a deep portfolio of partnerships Our partner pipeline is progressing and expanding Recent transaction creates robust financial position that fully funds operations, creates an opportunity to unlock value, and positions the business for future growth 26 OmniAb

View entire presentation